Relay Therapeutics

General Information
Business:

 

We are a clinical-stage precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights may enable us to more effectively drug protein targets that previously have been intractable (i.e. inadequately drugged or undruggable). 

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 122
Founded: 2015
Contact Information
Address 399 Binney Street, 2nd Floor, Cambridge, MA 02139, US
Phone Number (617) 370-8837
Web Address http://www.relaytx.com
View Prospectus: Relay Therapeutics
Financial Information
Market Cap $1386.8mil
Revenues $0 mil (last 12 months)
Net Income $-86.0 mil (last 12 months)
IPO Profile
Symbol RLAY
Exchange NASDAQ
Shares (millions): 14.7
Price range $16.00 - $18.00
Est. $ Volume $249.9 mil
Manager / Joint Managers J.P. Morgan/ Goldman Sachs/ Cowen/ Guggenheim Securities
CO-Managers -
Expected To Trade: 7/16/2020
Day: Thursday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change